GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AB Science (XPAR:AB) » Definitions » Scaled Net Operating Assets

AB Science (XPAR:AB) Scaled Net Operating Assets : -0.58 (As of Jun. 2024)


View and export this data going back to 2010. Start your Free Trial

What is AB Science Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

AB Science's operating assets for the quarter that ended in Jun. 2024 was €13.85 Mil. AB Science's operating liabilities for the quarter that ended in Jun. 2024 was €28.61 Mil. AB Science's Total Assets for the quarter that ended in Dec. 2023 was €25.50 Mil. Therefore, AB Science's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was -0.58.


AB Science Scaled Net Operating Assets Historical Data

The historical data trend for AB Science's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AB Science Scaled Net Operating Assets Chart

AB Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.36 -1.87 -0.79 -0.89 -0.34

AB Science Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.98 -0.88 -0.61 -0.24 -0.58

Competitive Comparison of AB Science's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, AB Science's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AB Science's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AB Science's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where AB Science's Scaled Net Operating Assets falls into.



AB Science Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

AB Science's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(19.433-27.408)/23.841
=-0.33

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=25.499 - 6.066
=19.433

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=46.509 - 16.988 - 2.113
=27.408

AB Science's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jun. 2024 )
=(Operating Assets (Q: Jun. 2024 )-Operating Liabilities (Q: Jun. 2024 ))/Total Assets (Q: Dec. 2023 )
=(13.854-28.608)/25.499
=-0.58

where

Operating Assets(Q: Jun. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=22.982 - 9.128
=13.854

Operating Liabilities(Q: Jun. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=47.581 - 16.882 - 2.091
=28.608

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AB Science Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of AB Science's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


AB Science Business Description

Industry
Traded in Other Exchanges
Address
3, Avenue George V, Paris, FRA, 75008
AB Science is a France-based pharmaceutical company specialized in the research, discovery, development, and marketing of protein kinase inhibitors. It is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine.